Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib in c-KIT mutated or amplified melanoma
NCT01168050Phase 2Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2010
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nilotinib in melanoma, sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
nilotinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01168050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01168050.